National Vision Holdings, Inc. (NASDAQ: EYE) ("National Vision" or the "Company") today reported its financial results for the fourth quarter and fiscal year ended December 28, 2024, and is providing ...
Scientists worry there will be immediate harm from the Trump administration's latest federal workforce cuts, which hit NOAA ...
Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...
More states are loosening vaccine mandates, scaling back vaccine promotion efforts and taking other steps likely to lower ...
Operator Good afternoon, and welcome to the Sarepta Therapeutics fourth quarter and full year 2024 financial results ...
Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...
As bird flu cases inundate more poultry and dairy farms, state officials worry that the Trump administration's firings of ...
ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...
Coeur d’Alene found itself in the national spotlight again on Feb. 22, this time after plainclothes security dragged ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, the growing measles outbreak in Texas, ...